| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Nucleosome assembly protein 1-like 1 (NAP1L1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY430096 | 100 ug | ORIGENE TECHNOLOGIES |
| 5'-nucleotidase, cytosolic IB (NT5C1B), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424317 | 100 ug | ORIGENE TECHNOLOGIES |
| Nucleosome assembly protein 1-like 1 (NAP1L1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY417929 | 100 ug | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS801443 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS803231 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500002 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500003 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500004 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500005 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500006 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500007 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500062 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500063 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500064 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500065 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500066 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500067 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500073 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500074 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500207 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500208 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500410 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500411 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500068 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500412 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500413 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500485 | 5x5um | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) (NR3C1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY422725 | 100 ug | ORIGENE TECHNOLOGIES |
| Human Myometrium, normal from ORIGENE TECHNOLOGIES | CS500414 | 5x5um | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) (NR3C1), transcript variant 5 from ORIGENE TECHNOLOGIES | LY424874 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) (NR3C1), transcript variant 6 from ORIGENE TECHNOLOGIES | LY422680 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 2, group C, member 2 (NR2C2) from ORIGENE TECHNOLOGIES | LY401137 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 2, group C, member 1 (NR2C1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY418783 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 2, group C, member 1 (NR2C1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY422297 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 1, group D, member 1 (NR1D1) from ORIGENE TECHNOLOGIES | LY411944 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 1, group D, member 2 (NR1D2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417483 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 3, group C, member 2 (NR3C2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424465 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 2, group E, member 1 (NR2E1) from ORIGENE TECHNOLOGIES | LY418799 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 2, group E, member 3 (NR2E3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY414039 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 2, group E, member 3 (NR2E3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429495 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 2, group E, member 3 (NR2E3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY402296 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 2, group F, member 6 (NR2F6) from ORIGENE TECHNOLOGIES | LY401603 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 2, group F, member 2 (NR2F2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412132 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 2, group F, member 2 (NR2F2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY428730 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 1, group H, member 2 (NR1H2) from ORIGENE TECHNOLOGIES | LY402093 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 1, group H, member 4 (NR1H4) from ORIGENE TECHNOLOGIES | LY401577 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 1, group H, member 3 (NR1H3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401738 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 1, group I, member 2 (NR1I2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401282 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 1, group I, member 3 (NR1I3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY421437 | 100 ug | ORIGENE TECHNOLOGIES |
| Nuclear receptor subfamily 1, group I, member 3 (NR1I3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY425868 | 100 ug | ORIGENE TECHNOLOGIES |